Fenofibrate Tablet
Product Images NDC 27241-117

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 27241-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

160mg (Fenofibrate 160mg)

160mg (Fenofibrate 160mg)
This is a medication package with NDC code 27241-117-03 containing 90 tablets of Fenofibrate, which is used to lower cholesterol and triglycerides in the blood. The tablets come in a child-resistant container and must be kept at room temperature to protect them from moisture. The dosage information is available on the package insert. This medication is manufactured by Ajanta Pharma USA Inc. in India.*
FDA Label Image

54mg (Fenofibrate 54mg)

54mg (Fenofibrate 54mg)
This is a package of Fenofibrate Tablets, USP containing 90 film-coated tablets of 54mg each. The package is child-resistant and should be stored at room temperature between 15°C to 30°C protected from moisture. The medication should be kept out of reach of children and dispensed in a tight container with a child-resistant closure. See package insert for the complete prescription information. The medication is manufactured by Ajanta Pharma in India and marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ.*
FDA Label Image

Structure (Fenofibrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.